Global Optical Coherence Tomography (OCT) Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Optical Coherence Tomography (OCT) Market Size

• The global optical coherence tomography (OCT) market size was valued at USD 1.66 billion in 2024 and is expected to reach USD 3.95 billion by 2032, at a CAGR of 11.45% during the forecast period
• This growth is driven by rising incidence of eye disorders

Optical Coherence Tomography (OCT) Market Analysis

• Optical Coherence Tomography (OCT) systems are essential imaging tools used in ophthalmology and various medical specialties to provide high-resolution, cross-sectional images of biological tissues
• The increasing adoption of OCT systems is primarily fueled by the rising global prevalence of chronic eye diseases, technological advancements in imaging speed and resolution, and growing demand for non-invasive diagnostic techniques
• North America is expected to dominate the optical coherence tomography (OCT) market with the largest market share of 35.61%, driven by the presence of major industry players, a well-developed healthcare infrastructure, growing adoption of advanced surgical imaging technologies, and supportive reimbursement policies for intraoperative procedures
• Asia-Pacific is projected to register the highest growth rate in the optical coherence tomography (OCT) market during the forecast period, driven by rapid advancements in healthcare infrastructure, increasing surgical volumes, growing awareness of advanced surgical imaging technologies, and expanded access to healthcare in emerging economies
• The frequency domain OCT (FD-OCT) segment is expected to dominate the optical coherence tomography (OCT) market with the largest market share of 38.95%, due to its utilization of interferometric signals to enhance imaging speed by up to 50 times, resulting in a higher number of images captured per unit area and driving greater industry adoption during the forecast period

Report Scope and Optical Coherence Tomography (OCT) Market Segmentation

Optical Coherence Tomography (OCT) Market Trends

“Integration of AI and Machine Learning in OCT Imaging”

• A growing trend in the optical coherence tomography (OCT) market is the integration of artificial intelligence (AI) and machine learning (ML) to enhance diagnostic accuracy, automate image analysis, and reduce interpretation time
• AI-powered OCT systems assist clinicians by automatically identifying disease biomarkers, segmenting retinal layers, and detecting early signs of ocular conditions with minimal human intervention.
• This trend is supported by the growing number of collaborations between medical imaging firms and AI developers to create smart, data-driven imaging solutions for clinical and research settings
• For instance, in 2023, ZEISS Medical Technology launched the ZEISS PLEX Elite 2.0 platform with AI-driven OCT angiography capabilities, significantly reducing diagnosis time for retinal diseases
• The integration of AI in OCT imaging is reshaping the ophthalmic diagnostics field, improving clinical workflows, and offering predictive insights for preventive healthcare strategies

Optical Coherence Tomography (OCT) Market Dynamics

Driver

“Expanding Use of OCT beyond Ophthalmology”

• A major driver in the OCT market is the broadening application scope of OCT systems beyond ophthalmology into cardiology, dermatology, oncology, and dentistry
• In cardiovascular interventions, OCT enables high-resolution imaging of coronary arteries to guide stent placements, while in dermatology, it aids in detecting skin cancer and monitoring treatment efficacy
• This multi-specialty utility increases OCT system adoption among a diverse range of medical institutions and enhances investment opportunities in OCT technology
• For instance, in 2023, Abbott reported increased usage of its Dragonfly OPTIS imaging catheter for intravascular OCT, used during percutaneous coronary interventions (PCI) to optimize stent placements
• The expansion of OCT applications is significantly accelerating market penetration and adoption across multiple clinical domains

Opportunity

“Rising Demand for Portable and Handheld OCT Devices”

• A key opportunity in the OCT market lies in the rising demand for compact, portable, and handheld OCT devices, particularly in primary care and telehealth settings
• These systems offer point-of-care diagnostics in remote or resource-limited areas, ensuring early detection and intervention for vision-threatening conditions
• The growing trend toward mobile health solutions and decentralized diagnostics is driving manufacturers to innovate compact OCT devices with wireless connectivity and user-friendly interfaces
• For instance, in 2024, Siloton, a U.K.-based startup, announced progress in developing a chip-based handheld OCT device aimed at combating age-related macular degeneration in community settings
• The rise of portable OCT solutions presents a lucrative growth avenue, especially in rural markets and emerging economies with limited access to specialized imaging equipment

Restraint/Challenge

“High Cost of Advanced OCT Systems and Limited Accessibility”

• A persistent challenge in the OCT market is the high cost of advanced OCT imaging systems, which restricts adoption among smaller clinics, especially in developing countries
• Maintenance, training requirements, and integration with existing healthcare IT systems further increase the total cost of ownership, limiting accessibility to only well-funded hospitals
• This pricing barrier creates a gap in diagnostic equity, where rural and underdeveloped regions often lack access to early and accurate OCT-based disease detection
• For instance, a 2023 market survey by the Asia-Pacific Ophthalmic Forum highlighted affordability as a top constraint in expanding OCT adoption across Southeast Asian nations
• Addressing cost-related challenges is crucial for achieving wider adoption of OCT systems and closing healthcare gaps in underserved regions

Optical Coherence Tomography (OCT) Market Scope

The market is segmented on the basis of technology, type, and application.

In 2025, the frequency domain OCT (FD-OCT) is projected to dominate the market with a largest share in product segment

The frequency domain OCT (FD-OCT) segment is expected to dominate the optical coherence tomography (OCT) market with the largest market share of 38.95% in 2025 due to its utilization of interferometric signals to enhance imaging speed by up to 50 times, resulting in a higher number of images captured per unit area and driving greater industry adoption during the forecast period.

The handheld OCT devices is expected to account for the largest share during the forecast period in type segment

In 2025, the handheld OCT devices segment is expected to dominate the market with the largest market share of 54.14% due to its integration with microelectromechanical systems (MEMS) with 3D imaging technology to enable the early diagnosis of various eye disorders, including diabetic retinopathy, macular degeneration, and glaucoma.

Optical Coherence Tomography (OCT) Market Regional Analysis

“North America Holds the Largest Share in the Optical Coherence Tomography (OCT) Market”

• North America dominates the optical coherence tomography (OCT) market with the largest market share of 35.61%, driven by the presence of major industry players, a well-developed healthcare infrastructure, growing adoption of advanced surgical imaging technologies, and supportive reimbursement policies for intraoperative procedures
• The U.S. holds the largest share within the region due to the widespread use of intraoperative MRI, CT, and ultrasound systems, the increasing number of complex surgical procedures, and constant innovations in imaging technologies designed for real-time surgical navigation. This trend is anticipated to further solidify the U.S.'s market leadership
• Increases in investments for neurosurgery, orthopedic surgery, and oncology applications, combined with favorable regulatory approvals and rising demand for precision surgeries, are poised to further strengthen North America's position

 “Asia-Pacific is Projected to Register the Highest CAGR in the Optical Coherence Tomography (OCT) Market”

• Asia-Pacific is expected to witness the highest growth rate in the optical coherence tomography (OCT) market, driven by rapid advancements in healthcare infrastructure, increasing surgical volumes, growing awareness of advanced surgical imaging technologies, and expanded access to healthcare in emerging economies
• Government initiatives supporting healthcare modernization, growing investments in hospital facilities, and the rising prevalence of chronic diseases requiring surgical interventions are contributing to this expansion
• In China and India, demand is surging due to healthcare reforms, public-private partnerships, and enhanced medical professional training in image-guided surgeries. These developments are setting the stage for continued growth across the region

Optical Coherence Tomography (OCT) Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Agfa-Gevaert Group (Belgium)
• Carl Zeiss Meditec AG (Germany)
• Heidelberg Engineering GmbH (Germany)
• Michelson Diagnostics Ltd (U.K.)
• Novacam Technologies Inc. (Canada)
• OPTOPOL Technology Sp. z o.o. (Poland)
• Metall Zug AG (Switzerland)
• TOPCON CORPORATION (Japan)
• Thorlabs, Inc. (U.S.)
• Abbott (U.S.)

Latest Developments in Global Optical Coherence Tomography (OCT) Market

• In October 2024, the Bristol-based health tech start-up Siloton secured USD 1,066,400 to further develop its Akepa OCT chip technology, which targets age-related macular degeneration (AMD), the leading cause of sight loss in the U.K. This funding will help support the commercial rollout, with plans to capture the first chip-based OCT image by the end of the year and release a research version in 2025
• In May 2024, Palleos Healthcare GmbH, an oncology-focused CRO, and OCT Global SA, under OCT Clinical, merged to create a stronger presence in clinical research. The merger, backed by Swiss XlifeSciences AG, represents a significant milestone, fostering collaboration and growth in the clinical research sector
• In February 2024, the Advanced Research Projects Agency for Health (ARPA-H) announced a USD 20 million initiative to develop a compact and affordable optical coherence tomography (OCT) device. This initiative is aimed at improving early detection and intervention for eye diseases, potentially preventing severe visual impairments
• In April 2022, Alcon expanded its training and education offerings with the launch of the Alcon Fidelis Virtual Reality (VR) Ophthalmic Surgical Simulator. This portable VR tool is designed to aid cataract surgeons in training, enhancing their skills in a virtual environment
• In January 2022, Haag-Streit UK (HS-UK) introduced the Optovue iScan80, a high-speed OCT system. Ideal for practices seeking an affordable and versatile solution, the device features a compact design that integrates the operator interface, display, patient interface, and scan head into a single console, making it perfect for small spaces

SKU-7726